LIU Xiaolu, LI Baoping, SHEN Fuhai, SUN Zhiping, ZHAO Yongmei, HOU Bowen, GAO Lini, LI Qianqian, LI Xinyu, MA Chaoyi. Changes in intestinal flora of coal workers' pneumoconiosis patients after tetrandrine intervention[J]. Journal of Environmental and Occupational Medicine, 2024, 41(6): 625-631. DOI: 10.11836/JEOM23449
Citation: LIU Xiaolu, LI Baoping, SHEN Fuhai, SUN Zhiping, ZHAO Yongmei, HOU Bowen, GAO Lini, LI Qianqian, LI Xinyu, MA Chaoyi. Changes in intestinal flora of coal workers' pneumoconiosis patients after tetrandrine intervention[J]. Journal of Environmental and Occupational Medicine, 2024, 41(6): 625-631. DOI: 10.11836/JEOM23449

Changes in intestinal flora of coal workers' pneumoconiosis patients after tetrandrine intervention

Funds: This study was funded.
More Information
  • Corresponding author:

    LI Baoping, E-mail: lbp00@sohu.com

  • Received Date: December 30, 2023
  • Accepted Date: May 07, 2024
  • Available Online: July 02, 2024
  • Background 

    Pneumoconiosis is a widespread occupational disease in China at present. As a type of lung diseases, its pathological damage is mainly irreversible fibrotic changes in the lungs. Several studies have shown that the occurrence and development of lung diseases such as coal workers' pneumoconiosis are closely related to intestinal flora.

    Objective 

    To observe intestinal flora of coal workers' pneumoconiosis patients based on the results of 16SrDNA high-throughput sequencing and evaluate the changes of intestinal flora after treatment with tetrandrine tablets.

    Methods 

    A total of 80 patients with coal workers' pneumoconiosis attending the outpatient clinic of the Department of Occupational Diseases of the Emergency General Hospital from April to July 2022 were enrolled. All patients were treated with tetrandrine tablets for 4 weeks, with group A before the treatment of tetrandrine tablets and group B after the treatment. In the same period, 24 healthy controls (group C) were set up. Stool samples were collected before and after the treatment. Using 16SrDNA high-throughput sequencing, gene V3-V4 sequencing technology, and bioinformatic analysis platform, we evaluated the intestinal flora after treatment by groups.

    Results 

    The dominant flora at the phylum level and genus level were the same across three groups. The relative abundances of phylum Bacteroidetes, Bifidobacterium, Bacteroides, and Facealibacterium in groups B and C were higher than those in group A, and the relative abundances of phy-lum Actinobacteria, genus Blautia, and genus Romboutsia in groups B and C were lower than those in group A (P<0.05). The relative abundances of genus Clostridium, genus Megamonas, and genus Lactobacillus in group C was lower than that in groups A and B (P<0.05). The alpha diversity analysis showed that the Chao1 index was higher in group A than in group C (P<0.01). Compared with group A, the Shannon index was higher in group B, and the increases of Simpson index were all statistically significant in stage I patients (P<0.05), but the differences in Chao1 index were not statistically significant (P>0.05). The differences in the values of Chao1 index, Shannon index, and Simpson index in stage Ⅱ and stage III patients were not statistically significant (P>0.05). The beta diversity analysis showed that the difference in flora structure between group A and group C was statistically significant (P<0.05); the differences in flora structure before and after treatment in the same stage patients were statistically significant (P<0.05). The partial least squares discriminant analysis (PLS-DA) showed that there were significant differences between group A and group C, and between group A and group B. The LEfSe analysis showed that the significant markers contributing to the differences were basically the same in stage I, stage Ⅱ, and stage Ⅲ after treatment, which were mainly phylum Bacteroidetes and its subordinate groups, class Negativicutes, or-der Selenomonas, and genus Facealibacterium.

    Conclusion 

    There are differences in the distribution of flora between coal workers' pneumoconiosis patients and healthy individuals, and the structure and relative abundance of intestinal flora are changed and the number of beneficial flora is increased after treatment with tetrandrine tablets.

  • [1]
    中华预防医学会劳动卫生与职业病分会职业性肺部疾病学组. 尘肺病治疗中国专家共识(2024年版)[J]. 环境与职业医学, 2024, 41(1): 1-21.

    Occupational Lung Disease Group of Labor Hygiene and Occupational Diseases Branch of Chinese Preventive Medicine Association. Consensus of Chinese experts on pneumoconiosis treatment (2024)[J]. J Environ Occup Med, 2024, 41(1): 1-21.
    [2]
    YAO Y, WEI T, ZHANG H, et al. Characteristics of diagnosed and death cases of pneumoconiosis in Hubei Province, China, 1949-2019[J]. Int J Environ Res Public Health, 2022, 19(23): 15799. doi: 10.3390/ijerph192315799
    [3]
    ZHANG D, LI S, WANG N, et al. The cross-talk between gut microbiota and lungs in common lung diseases[J]. Front Microbiol, 2020, 11: 301. doi: 10.3389/fmicb.2020.00301
    [4]
    张鑫. 肺癌患者呼吸道菌群结构及代谢组特征分析与比较研究[D]. 上海: 海军军医大学, 2019.

    ZHANG X. Analysis and comparative study on characteristics of respiratory microbiomes structure and metabolome in patients with lung cancer[D]. Shanghai: Naval Medical University, 2019.
    [5]
    DICKSON R P, ERB-DOWNWARD J R, FALKOWSKI N R, et al. The lung microbiota of healthy mice are highly variable, cluster by environment, and reflect variation in baseline lung innate immunity[J]. Am J Respir Crit Care Med, 2018, 198(4): 497-508. doi: 10.1164/rccm.201711-2180OC
    [6]
    KATAYAMA Y, YAMADA T, SHIMAMOTO T, et al. The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer[J]. Transl Lung Cancer Res, 2019, 8(6): 847-853. doi: 10.21037/tlcr.2019.10.23
    [7]
    LAI H C, LIN T L, CHEN T W, et al. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinⅡ lipopolysaccharide[J]. Gut, 2022, 71(2): 309-321. doi: 10.1136/gutjnl-2020-322599
    [8]
    SHI H, ZHAO T, GENG R H, et al. The associations between gut microbiota and chronic respiratory diseases: a Mendelian randomization study[J]. Front Microbiol, 2023, 14: 1200937. doi: 10.3389/fmicb.2023.1200937
    [9]
    代金娥. 尘肺病患者下呼吸道菌群及代谢物结构特征研究[D]. 昆明: 昆明医科大学, 2021.

    DAI J E. Study on microflora and metabolites structure of lower respiratory tract in patients with pneumoconiosis[D]. Kunming: Kunming Medical University, 2021.
    [10]
    ZHOU Y, CHEN L, SUN G, et al. Alterations in the gut microbiota of patients with silica-induced pulmonary fibrosis[J]. J Occup Med Toxicol, 2019, 14: 5. doi: 10.1186/s12995-019-0225-1
    [11]
    戴连英, 赵彬, 林晓杰. 汉防己甲素治疗尘肺的疗效及对免疫功能的影响[J]. 内科, 2017, 12(2): 239-240,273.

    DAI L Y, ZHAO B, LIN X J. Therapeutic efficacy of tetrandrine in the treatment of pneumoconiosis and its effect on the immune function[J]. Intern Med, 2017, 12(2): 239-240,273.
    [12]
    职业性尘肺病的诊断: GBZ 70—2015[S]. 北京: 中国标准出版社, 2016.

    Diagnosis of occupational pneumoconiosis: GBZ 70—2015[S]. Beijing: China Standard Press, 2016.
    [13]
    HUANG S, LI J, ZHU Z, et al. Gut microbiota and respiratory infections: insights from mendelian randomization[J]. Microorganisms, 2023, 11(8): 2108. doi: 10.3390/microorganisms11082108
    [14]
    ADAK A, KHAN M R. An insight into gut microbiota and its functionalities[J]. Cell Mol Life Sci, 2019, 76(3): 473-493. doi: 10.1007/s00018-018-2943-4
    [15]
    LI Y, XIAO K, XIAO S, et al. Difference in intestinal flora and characteristics of plasma metabonomics in pneumoconiosis patients[J]. Metabolites, 2022, 12(10): 917. doi: 10.3390/metabo12100917
    [16]
    庄思琪, 毛怡心, 邓富昌, 等. 健康老年人肠道菌群宏基因组与16S rDNA测序的比较研究[J]. 中华预防医学杂志, 2022, 56(11): 1618-1624.

    ZHUANG S Q, MAO Y X, DENG F C, et al. Comparative analysis of metagenomic and 16S rDNA sequencing in gut microbiota of healthy elderly[J]. Chin J Prev Med, 2022, 56(11): 1618-1624.
    [17]
    ZHAO Y, LIU Y, LI S, et al. Role of lung and gut microbiota on lung cancer pathogenesis[J]. J Cancer Res Clin Oncol, 2021, 147(8): 2177-2186. doi: 10.1007/s00432-021-03644-0
    [18]
    KIM S, GOEL R, KUMAR A, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure[J]. Clin Sci, 2018, 132(6): 701-718. doi: 10.1042/CS20180087
    [19]
    ARUMUGAM M, RAES J, PELLETIER E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473(7346): 174-180. doi: 10.1038/nature09944
    [20]
    WILMANSKI T, DIENER C, RAPPAPORT N, et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans[J]. Nat Metab, 2021, 3(2): 274-286. doi: 10.1038/s42255-021-00348-0
    [21]
    LUIS A S, BRIGGS J, ZHANG X, et al. Dietary pectic glycans are degraded by coordinated enzyme pathways in human colonic Bacteroides[J]. Nat Microbiol, 2018, 3(2): 210-219.
    [22]
    RAMSHEH M Y, HALDAR K, ESTEVE-CODINA A, et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis[J]. Lancet Microbe, 2021, 2(7): e300-e310. doi: 10.1016/S2666-5247(21)00035-5
    [23]
    HORN K J, SCHOPPER M A, DRIGOT Z G, et al. Airway Prevotella promote TLR2-dependent neutrophil activation and rapid clearance of Streptococcus pneumoniae from the lung[J]. Nat Commun, 2022, 13(1): 3321. doi: 10.1038/s41467-022-31074-0
    [24]
    O’DWYER D N, ASHLEY S L, GURCZYNSKI S J, et al. Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2019, 199(9): 1127-1138. doi: 10.1164/rccm.201809-1650OC
    [25]
    彭金碧, 韩宇浩, 顾倚岑, 等. 矽肺小鼠肺部菌群失调影响肺上皮间质转化过程[J]. 中国职业医学, 2022, 49(5): 514-521.

    PENG J B, HAN Y H, GU Y C, et al. Dysbiosis of lung commensal bacteria in the process of lung epithelial-mesenchymal transition in mice with silicosis[J]. China Occup Med, 2022, 49(5): 514-521.
    [26]
    TANG J, XU L, ZENG Y, et al. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway[J]. Int Immunopharmacol, 2021, 91: 107272. doi: 10.1016/j.intimp.2020.107272
    [27]
    ZHANG Y, LIANG J, CAO N, et al. Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals[J]. Cell Death Discov, 2022, 8(1): 500. doi: 10.1038/s41420-022-01291-z
    [28]
    SONG M Y, WANG J X, SUN Y L, et al. Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages[J]. Acta Pharmacol Sin, 2022, 43(5): 1274-1284. doi: 10.1038/s41401-021-00693-6
    [29]
    ZHAO N, CHEN Q G, CHEN X, et al. Intestinal dysbiosis mediates cognitive impairment via the intestine and brain NLRP3 inflammasome activation in chronic sleep deprivation[J]. Brain Behav Immun, 2023, 108: 98-117. doi: 10.1016/j.bbi.2022.11.013
    [30]
    KAWAMOTO S, TRAN T H, MARUYA M, et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut[J]. Science, 2012, 336(6080): 485-489. doi: 10.1126/science.1217718
    [31]
    SCHIRMER M, SMEEKENS S P, VLAMAKIS H, et al. Linking the human gut microbiome to inflammatory cytokine production capacity[J]. Cell, 2016, 167(4): 1125-1136.e8. doi: 10.1016/j.cell.2016.10.020
    [32]
    张志玲, 何娜, 徐晓涵, 等. 汉防己甲素片治疗尘肺病的药物临床综合评价[J]. 中华劳动卫生职业病杂志, 2023, 41(3): 217-221.

    ZHANG Z L, HE N, XU X H, et al. Drug clinical comprehensive evaluation of tetrandrine in the treatment of pneumoconiosis[J]. Chin J Ind Hyg Occup Dis, 2023, 41(3): 217-221.
  • Related Articles

    [1]ZHANG Limin, LIU Chen, LIU Yumei, WU Xueqian, SHU Ming, ZHOU Jian, XU Dongqun, WANG Qin, LI Wanwei, LI Xiaohong. Effect of vitamin C on intestinal flora disorders in Cr(VI)-contaminated mice[J]. Journal of Environmental and Occupational Medicine, 2024, 41(7): 807-813. DOI: 10.11836/JEOM24058
    [2]TANG Jiajie, ZHENG Jiaxue, SONG Qian, KANG Huiwen, CUI Yaqi, ZHANG Xuemei, SHANG Xuan, JIANG Shoufang. Role of intestinal flora and 5-HT in depression- and anxiety-like behaviors in mice exposed to PM2.5 [J]. Journal of Environmental and Occupational Medicine, 2022, 39(12): 1343-1349. DOI: 10.11836/JEOM22100
    [3]WAN Ping, SHEN Weitao, PENG Zhenyan, LIU Ran. Characteristic intestinal flora and associated biomarkers in esophageal cancer based on PacBio SMRT sequencing[J]. Journal of Environmental and Occupational Medicine, 2022, 39(9): 1011-1020. DOI: 10.11836/JEOM22065
    [4]CUI Yanan, SHE Xiaojun, LI Ningning, ZHANG Xiuzhi, CUI Bo, YU Shanfa. Effects of noise exposure on structure and functional prediction of intestinal microbiota in rats[J]. Journal of Environmental and Occupational Medicine, 2022, 39(2): 179-185. DOI: 10.11836/JEOM21278
    [5]HUANG Hongqian, LI Fengmin, ZHANG Aihua, HAN Xue. Effects of intestinal flora dysregulation on mercury concentrations in tissues and feces in methylmercury treated mice[J]. Journal of Environmental and Occupational Medicine, 2021, 38(5): 524-529. DOI: 10.13213/j.cnki.jeom.2021.20532
    [6]HE Qin, LIU Yongquan, WANG Zhi, LI Yanwen, RONG Kaiping. Effects of tetrandrine combined with modified pursed lip breathing on silicosis patients complicated with stable chronic obstructive pulmonary disease[J]. Journal of Environmental and Occupational Medicine, 2021, 38(3): 282-287. DOI: 10.13213/j.cnki.jeom.2021.20275
    [7]LIU Min, LIU Li-li, CHEN Jia-bin. Research progress on effects of exposure to heavy metals on gut microbiome and associations of gut microbiome with related diseases in infants and children[J]. Journal of Environmental and Occupational Medicine, 2019, 36(2): 186-192, 195. DOI: 10.13213/j.cnki.jeom.2019.18360
    [8]ZHU Hang-ju, WANG Feng, YANG Xian, WANG Zhao-dan, XIA Hui, CHENG Chen, SUN Gui-ju. Effects of different oils on intestinal microbiota of mice[J]. Journal of Environmental and Occupational Medicine, 2017, 34(11): 995-998. DOI: 10.13213/j.cnki.jeom.2017.17294
    [9]DANG Zhan-cui , SONG Qi-ru , LI Wu-ping , YANG Wen-hai , WU Xiang-lin . Gene Polymorphisms of Interleukin-12B+1188A/C and Susceptibility of Coal Worker's Pneumoconiosis in Han Ethnic Group in Ningxia Area[J]. Journal of Environmental and Occupational Medicine, 2011, 28(9): 535-538.
    [10]YANG Wen-hai , YANG Jin , WANG Fa-xuan , WANG Ya-na , WANG Ling , CHEN Lili , SONG Qi-ru . The Distribution of TGF-β1 Gene-509 C/T Polymorphism in Coal Worker's Pneumoconiosis Patients in Ningxia Area[J]. Journal of Environmental and Occupational Medicine, 2010, 27(11): 670-672.
  • Other Related Supplements

Catalog

    Article views (92) PDF downloads (14) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return